LaunchBio Inc.’s Post

🥂 We're continuing our 20th anniversary celebrations with the second video in our series honouring our life sciences ecosystem and how our community has grown. 🤔 In today's film, Luc Henry, Founder and CEO of Limula, summarises how a life sciences company affects and is affected by its environment: 'Now that I'm building a company, the more we advance, the more I realise that it's critical to foster the ecosystem – the talent and the people. The more people have been through the start-up journey, whether they're still in it as innovators or whether they're successful entrepreneurs, the more value it creates in the region.' 🙏 Thanks to Luc, Henri Kornmann (Head of Ferring Pharmaceuticals's Biologics Innovation Centre), Siew-Veena Sahi (Co-Founder and CEO of Testmate Health) and Pierre-Jean Wipff (Innovation and Partnerships Director here at Biopôle Lausanne) for their contributions to today's video.

Let's connect at #bio2024 and talk #clinicaltrials #patientexperience #patientengagement #patientreportedoutcomes

📣 LET'S MEET! ✔️ Our Pace® Life Sciences team will be at Biotech Showcase & BIO Partnering at JPM Week in San Francisco. We would love to hear the latest about your program, explore synergies and share how our strategic investments and plans could make us the perfect CRDMO partner! Comment below or DM me to set up a time to connect!

Launching a biotech is challenging but the right partners can help you overcome major barriers and reach value inflection points. Pick the best partners who take the journey with you! Black Swann Consulting Group

One company optimizing protein conjugates, one company screening for optimal efficacy and therapeutic window of protein conjugates. Well played, #RESIBoston2024 #ADCs #startup #proteinconjugation

📆 Join Camille Samuels of Venrock, Tim Scott of Biocom California, Nina Kjellson of Canaan Partners and Greg Bisconti of JLL for a life sciences #venturecapital outlook webinar. What are the lessons from 2024 and what's in store for 2025? Regardless of fluctuation, venture and other risk capital investments have fueled #biotech innovation and set the groundwork for life sciences industry growth. Both early stage and mature life sciences companies can benefit from the insights shared. Register now >> #JLLLifeSciences #biotechventurecapital

Calling all early stage biotech founders... Whether you are still at concept/ idea phase or already launched your early stage fundraising, Black Swann Consulting Group would love to help you on your journey. With experience in both scientific, business and fundraising plans and strategies, we'd love to help make your early stage biotech a success. We only win, if you win! Success based fee so we take the risk with you and share the conviction with you! Let's talk! #Biotech #GoToMarket #ProductMarketFit #FounderMarketFit #DrugDiscovery #CommercialLifeScience #LifeScience #BiotechPlatform #TechBio

At Goodland Pharma, our journey began with a profound passion for the triumphs of life science. Founded by visionaries deeply entrenched in the industry, we've cultivated global teams that have played pivotal roles in countless scientific breakthroughs. What sets us apart? Our seasoned expertise isn't just surface-level – it delves deep into your world, comprehending the intricate nuances of regulations and the critical factors that drive clinical trial success. Get started here: https://lnkd.in/g_z8FmWD #GoodlandPharma #TailoredSolutions #LifeScience #ClinicalTrials

A lab without Labguru? It wasn't an option for Dr. Alon Silberman, MitoCareX Bio Co-Founder and Chief Scientific Officer. MitoCareX Bio is a successful early-stage drug discovery startup. They've been using Labguru since day 1. With us, they have: ⏱️ Saved 3+ hours every week 💰 Saved $300/month thanks to effective inventory management 🧪 Simplified experiment planning & improved consistency of results 🗃️ Made lab data centralized, searchable, and traceable We interviewed Dr. Alon Silberman, MitoCareX Bio Co-Founder and Chief Scientific Officer, to discover why he couldn't imagine lab life without Labguru. This is what he said 👇 📌Full Case study: https://bit.ly/4dEDQfn

Welcome to the YZR family DeepLife! 🧬 YZR led the $10m Series A round together with Turenne Groupe and joined by Beiersdorf, Groupe Prunay and the existing investors. DeepLife is a groundbreaking techbio company leveraging a proprietary database to provide digital twins of cells to household names in the pharma, biotech and adjacent industries. Its revolutionary approach for drug discovery increases speed and precision in testing novel drug combinations, particularly for diseases once deemed untreatable. We are excited to join the company on its mission to accelerate drug discovery and to further expand their footprint from France across Europe and beyond. A huge congratulations to Jonathan Baptista, Jean-Baptiste MORLOT and the whole team on this great success! You can find the link to the Sifted Article in the first comment. 👇 #Healthtech #Techbio #Venturecapital